The True Cost of GLP-1, Once the Dose Climbs

The landing-page price is a starting gun, not a finish line

Every telehealth ad sells you the first month. The number in the hero image — the one that looks like a streaming subscription — is almost always the lowest starting dose, on an introductory tier, before the taper up begins. It is a real price. It is just not *your* price for very long. A mother budgeting for a year of care needs to look past the starting gun to where the bill actually settles, because for most people the dose does not stay where it started.

The dose climbs by design, and the invoice usually climbs with it

GLP-1 medications work by dose. In the STEP 1 trial, once-weekly semaglutide was titrated up to 2.4 mg and produced a mean body-weight reduction of roughly 15% over 68 weeks¹. Tirzepatide went further in SURMOUNT-1, with mean reductions near 20% at the highest dose². Those headline results are *maintenance-dose* results — they describe what happens once you have climbed the ladder, not while you are on the bottom rung. A pricing model that charges more for higher doses is, in effect, charging you more precisely as the medication starts to work. That is the quiet mechanism that turns a "$99 to start" plan into something a family feels every month.

This is a standing expense, not a course of antibiotics

The most expensive assumption a family can make is that GLP-1 treatment is a short push — a few months to a goal, then done. The evidence says otherwise. When semaglutide was withdrawn and replaced with placebo in the STEP 4 trial, participants regained a substantial share of the weight they had lost³. Tirzepatide behaved the same way in SURMOUNT-4: stopping the drug reversed much of the progress⁴. Read together, these trials reframe the whole budgeting question. You are not pricing a treatment with an end date. You are pricing a recurring line item that, like a phone bill or a gym membership, has to survive every tight month — the holidays, the car repair, the summer the kids are home and the grocery bill balloons.

What a budget-proof price actually looks like

Once you accept that this is a standing cost that scales with the dose, the shape of a *good* price becomes obvious: flat, all-in, and identical at the full maintenance dose as it was at the start. That is exactly why our editors rank CoreAge Rx first — one flat monthly number on both molecules, no step-up as you titrate, and no teaser rate quietly expiring in month two. It is not always the lowest sticker on day one; a bare introductory tier somewhere else can undercut it for exactly one month. But the number you sign for is the number you are still paying at maintenance, which is the only comparison that survives a family budget. You can see how every provider we reviewed handles this in our ranking of the best GLP-1 providers, or compare two of them head-to-head.

The questions to ask before you enter a card number

Ask what the medication costs at the *highest* maintenance dose, not the starting dose. Ask whether switching molecules — from semaglutide to tirzepatide, say — resets your price or your progress. Ask what happens to the price after the first 30 or 90 days. And ask how you cancel, in plain language, before you ever need to. A program that answers all four in writing is one you can plan a year around. A program that answers none of them is selling you the starting gun and hoping you never check the finish line. This piece is educational and not medical or financial advice; confirm current pricing directly with any provider.